Product Information
CETIRIZINE HCL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0510 per EA under NDC 00378363501. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378363501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076677On Market Since
12/27/2007
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0510 per EA |
|---|---|
| All-time high | $0.0858 (Nov 13, 2019) |
| All-time low | $0.0382 (Nov 20, 2024) |
| 52-week high | $0.0510 |
| 52-week low | $0.0472 |
| Median price | $0.0557 |
| Average price | $0.0568 |
| Largest weekly change | +48.6% (May 22, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cetirizine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0510 per EA (NDC 00378363501), effective Jun 24, 2026.
How has the price of CETIRIZINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG TABLET has declined 22.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG TABLET has ranged from a low of $0.0382 (Nov 20, 2024) to a high of $0.0858 (Nov 13, 2019), with a median of $0.0557 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CETIRIZINE HCL 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CETIRIZINE HCL 5 MG TABLET?
CETIRIZINE HCL 5 MG TABLET (NDC 00378363501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification